Clinical Trial Update: The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)

View source ↗

Summary

The CALM-PD cohort study comparing initiating pramipexole versus levodopa in early Parkinson's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole (pramipexole)
• levodopa (levodopa)

Snippet

Sponsor: University of Rochester | Conditions: Parkinson's Disease | Status: TERMINATED